Search Results - "MODI, KUSHAL"
-
1
The burden of anxiety among a nationally representative US adult population
Published in Journal of affective disorders (01-09-2023)“…Anxiety disorders are highly prevalent and are associated with a significant humanistic and economic burden. This study evaluates the impact of anxiety…”
Get full text
Journal Article -
2
Treatment patterns in patients with newly diagnosed COPD in the USA
Published in BMC pulmonary medicine (17-08-2024)“…Prompt and effective management with maintenance therapy (single or dual bronchodilator therapy) is recommended after the initial diagnosis of chronic…”
Get full text
Journal Article -
3
Anticancer Activity of Region B Capsaicin Analogs
Published in Journal of medicinal chemistry (13-04-2023)“…The heterocyclic vanilloid compound capsaicin is responsible for the spicy and pungent flavor of chili peppers. Several convergent studies have shown that…”
Get full text
Journal Article -
4
An Experimental Protocol for the Boyden Chamber Invasion Assay With Absorbance Readout
Published in Bio-protocol (05-08-2024)“…The phenomenon of cell invasion is an essential step in angiogenesis, embryonic development, immune responses, and cancer metastasis. In the course of cancer…”
Get full text
Journal Article -
5
The economic and humanistic burden of bipolar disorder in adults in the United States
Published in Annals of general psychiatry (24-03-2023)“…Bipolar disorder is associated with functional impairment and diminished health-related quality of life (HRQoL). The purpose of this study was to estimate the…”
Get full text
Journal Article -
6
An Improved Protocol for the Matrigel Duplex Assay: A Method to Measure Retinal Angiogenesis
Published in Bio-protocol (05-12-2023)“…Neovascular diseases of the retina, such as diabetic retinopathy (DR) and age-related macular degeneration (AMD), are proliferative retinopathies involving the…”
Get full text
Journal Article -
7
Real-World Treatment Patterns Among Patients with Myelodysplastic Syndromes Initiating Oral Decitabine and Cedazuridine or Intravenous/Subcutaneous Hypomethylating Agents
Published in Blood (02-11-2023)“…Introduction: Hypomethylating agents (HMAs) are recommended standard of care for patients with higher-risk myelodysplastic syndromes (HR-MDS). HMA therapies…”
Get full text
Journal Article -
8
Patient-Reported Outcomes Among Adults with Hemophilia A on Prophylactic Treatment
Published in Blood (15-11-2022)Get full text
Journal Article -
9
Time toxicity for patients receiving oral versus parenteral hypomethylating agents for myelodysplastic syndromes/neoplasms (MDS)
Published in Journal of clinical oncology (01-06-2024)“…6568 Background: Patients spend substantial time receiving cancer care. Patients with higher-risk MDS treated with hypomethylating agents (HMAs) are generally…”
Get full text
Journal Article -
10
EXPLORING THE GAP BETWEEN INITIAL DIAGNOSIS AND TREATMENT INTERVENTION IN PATIENTS WITH COPD IN THE USA: EVALUATION OF PHARMACOLOGIC PATTERNS
Published in Chest (01-10-2023)Get full text
Journal Article -
11
-
12
Attitudes and beliefs of healthcare providers toward vaccination in the United States: A cross-sectional online survey
Published in Vaccine (02-12-2024)“…Healthcare providers' (HCPs') beliefs and practices regarding vaccination influence vaccine acceptance in patients. To describe HCPs' beliefs and practices…”
Get full text
Journal Article -
13
First-line treatment preferences for advanced melanoma among oncologists and patients in the US: A discrete choice experiment
Published in Journal of clinical oncology (01-06-2024)“…9539 Background: NCCN guidelines recommend nivolumab + ipilimumab, nivolumab + relatlimab, and anti-PD-1 monotherapy as category 1 preferred first-line (1L)…”
Get full text
Journal Article -
14
MDS-772 Time Toxicity for Patients Receiving Oral Versus Parenteral Hypomethylating Agents for Myelodysplastic Syndromes/Neoplasms
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)“…Older patients with higher-risk myelodysplastic syndromes/neoplasms (MDS) treated with HMAs have median life expectancy of 11–17 months (Davidoff 2020)…”
Get full text
Journal Article -
15
Time Toxicity for Patients Receiving Oral Versus Parenteral Hypomethylating Agents for Myelodysplastic Syndromes/Neoplasms
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)Get full text
Journal Article -
16
-
17
P-233 Physician perspectives regarding conventional marrow testing and MRD assessments to guide decision-making in myeloma
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)Get full text
Journal Article -
18
MM-290 Physician Perspectives Regarding Conventional Marrow Testing and Measurable Residual Disease (MRD) Assessments to Guide Decision-Making in Myeloma
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)“…Decision-making in multiple myeloma (MM) is complex as numerous treatment options are available across multiple lines of therapy. A recent survey suggested…”
Get full text
Journal Article -
19
The Associations between Insomnia Severity and Health Outcomes in the United States
Published in Journal of clinical medicine (22-03-2023)“…Little is known about the associations between insomnia severity, insomnia symptoms, and key health outcomes. Using 2020 United States National Health and…”
Get full text
Journal Article -
20
Anti-cancer activity of capsaicin and its analogs in gynecological cancers
Published in Advances in cancer research (2024)“…Capsaicin is the hot and pungent ingredient of chili peppers. It is a potent pain-relieving agent and is often present in over-the-counter analgesic lotions…”
Get full text
Journal Article